Blue Horseshoe Stocks

VGTL, MELY, FROI, UNDR, IRBL | Today’s Stock Watchlist

VGTel, Inc. VGTL

Microelectronics Technology Co. MELY

These two plays both recently had news out, (VGTL News, MELY News) Over the past couple of days, we have seen an increase in volume on both of these stocks, as accumulation seems to have gotten underway in both cases.

As a result of the recent influx of activity, we will monitor VGTL and MELY on our watchlists, attempting to anticipate their next moves. On a side note, VGTL is also currently being promoted, just another reason to see how things play out with that one.

Fero Industries, Inc. FROI

FROI is beginning to exhibit signs of a recovery off its bottom, with a solid level of support at .008. The MACD is setting up nicely, and the RSI is above 50; right where we like to see it.

UnderSea Recovery Corporation UNDR

UNDR has been a great flipping stock since we added it to our radar. Yesterday, it held above the 200-day moving average of .0018, precisely as like we had hoped. Moving forward we would like to see UNDR continue to hold above that 200dma.

Inrob Tech, Ltd IRBL

IRBL came up on a bunch of scanners yesterday trading much higher than average volume, as a result we are adding it to our radars. We always love a good sub-penny momentum play, and IRBL fits that category.

UNDR | Undersea Recovery Corp. Breaks 200-Day Moving Average

UnderSea Recovery Corporation UNDR

Yesterday we stated that we were looking for UNDR to break past resistance at .0017, and indeed it has done just that. The stock has now breached the level of its 200-day moving average (.0018), and trades are now going off at .002.From yesterday’s low of .0009, UNDR has gained 122% overnight!

Moving forward, we’d like to see the stock hold above the 200-day moving average, building a higher level of support.

With volume trading well above average, this is one liquid sub-penny. We sincerely hope we were not the only ones who were able to capitalize on these explosive gains.

UNDR, HPCS, EFFI & Today’s Extended Watchlist

UnderSea Recovery Corporation UNDR

UNDR ran into a key level of resistance at .0017. We thought we might see a break past that yesterday, but alas, as we all know, no one can be right every time.

Moving forward, we’d like to see support hold above .001.

HPC POS System, Corp. HPCS

This is a momentum alert that came up on our scans yesterday after seeing a huge volume increase. HPCS was bouncing off of a relative bottom for the better part of February, and yesterday, it bumped its head into resistance at .03.

The .03’s are going to be the key resistance point after which we think the stock could really make some headway.

EffTec International, Inc. EFFI

EFFI has been under consolidation over the past few sessions after making a huge gain this year. The stock moved from .011 in January, to a high of .182 (1720%) After the expected pullback, EFFI seems to have found solid support at .13

The EFFI chart continues to set up for a golden cross, one of our favorite bullish indicators, so we want to just camp out and wait for that to come to pass.

Today’s Extended Watchlist:

AGCZ BUCS CRPZ

UNDR – Undersea Recovery Corporation

UnderSea Recovery Corporation UNDR

UNDR was added to our pre-market radar this morning after Friday’s volume explosion raised more than a few eyebrows. We like to add stocks to our tickers when we see high volatility, and rapidly increasing volume.

It has been awhile since we’ve come across a triple-0 stock that we felt was worthy of adding to our watchlist.

After gapping up to .0009 from Friday’s .0007 close, UNDR made an intraday move to .0017. That represents an 89% gain from today’s open, and 142% from Friday’s close.

Currently UNDR has traded almost 4x its 10-day average volume, and looks like it wants to test new highs as we head into the close. We’re going to reserve a spot on our tickers for UNDR as this wave of activity continues.

THQI, EFFI, UNDR, BPAX & Today’s Stock Watchlist

THQ, Inc. THQI

THQI was added to our watchlist as a possible bottom bounce-play. We have yet to see that bottom settle in. On Friday, the stock hit a new 52-wk low, but it appears as if it is still on the descent. The company has a PR out this morning:

AGOURA HILLS, Calif., Mar 05, 2012 (BUSINESS WIRE) — THQ Inc. (NASDAQ: THQI) today announced that THQ’s President and Chief Executive Officer Brian Farrell will make a presentation to investors at the Wedbush 2012 Technology, Media and Telecommunications: Management Access Conference on Wednesday, March 7, 2012, at 10:20 a.m. Eastern.

The presentation will be open to all interested investors through a live audio Web broadcast via the Internet on the Investor Relations Event Calendar page of THQ’s website located at http://investor.thq.com. An archived replay will also be available on the company’s website approximately 24 hours following the live broadcast.

EffTec International, Inc. EFFI

EFFI was added to our watchlist at midday on Feb. 28th as a momentum alert
At that time, the stock was trading around .13. What we saw next was a high of .181 the next morning, for a tidy 39% gain overnight!

Since then, the stock has consolidated to find a new level of support at our original alert price of .13, and we already know what this stock can do, so our eyes are open for more such bounce opportunities.

For those interested, a good place to start your DD here, would be with this EFFI investor presentation.

UnderSea Recovery Corporation UNDR

UNDR enjoyed a substantial momentum surge on Friday, trading sizable volume. It was observed bouncing off of a low of .0004, only to hit a high of .0009– That represents an intraday gain of over 100%.

As a result, Friday’s trading session saw abnormally high volume, and piqued our interest enough to warrant our paying of close attention this morning.

BioSante Pharmaceuticals, Inc. BPAX

We caught this stock at its 52-wk low. It was as low as .38 following our alert. 1.23 was the subsequent high, making for a 224% gainer.

BPAX had some significant news out this morning, outlining the favorable conclusion of round of testing on its GVAX Prostate cancer vaccine.

LINCOLNSHIRE, Ill., Mar 05, 2012 (BUSINESS WIRE) — BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced publication of results from a Phase I dose escalation clinical study that show its GVAX Prostate cancer vaccine in treating metastatic castration-resistant prostate cancer patients (mCRPC) in combination with ipilimumab (Ipi; Yervoy; BMS), resulted in 53 percent of patients achieving at least stable disease, with two patients showing clear regression of metastases. In addition, 23 percent of patients in the higher dose cohorts had confirmed partial PSA (prostate specific antigen) responses of greater than 50 percent from baseline.

Today’s Extended Watchlist:
CRPZ, ERII